Novosanis is an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.
Who is novosanis
Latest news
Breakthrough results on VAX-ID for kids at 12th Vaccine Conference
15/09/2018
Timothi Van Mulder will present Novosanis' breakthrough results on the development of a painless injection device for children at 12 th Vaccine Congress in Budapest, Hungary from September 16 to 19, 2018. His research on skin thickness in children from birth to adolescence as well as the...
Upcoming event
ESMO2018
Munich, Germany
242
Novosanis is excited to join ESMO for the first time and showcase our Colli-Pee device for first-void urine sampling and our VAX-ID drug delivery platform. Come and talk to our CEO, Vanessa Vankerckhoven & CTO, Koen Beyers.
Events
Regulatory
Team
News